
Prologue Medicines Bolsters Leadership with New Scientific Chief
Cambridge-based Prologue Medicines has named Stephen Harrison, Ph.D., as its new Chief Scientific Officer, tasking the veteran researcher with steering the company’s DELVE platform. The appointment coincides with the addition of Jason Silvers and Adrian Rawcliffe to the biotechnology firm’s Board of Directors as it seeks to scale its pipeline.
























